Skip to main content
. 2018 Oct 23;5(4):419–430. doi: 10.3233/JND-180338

Table 1.

Adherence to pulmonary function assessment using the HHD device

Group Adherence to HHD use*
Idebenone (n = 31) 76.3% (SD 22.0)
Placebo (n = 33) 75.5% (SD 21.1)
Total (n = 64) 75.9% (SD 21.5)

* Data is weighted mean (Standard Deviation, SD) of percentage of weeks in study with at least one home-based measurement.